Annual Operating Profit
-$190.51 M
+$117.88 M+38.22%
December 31, 2023
Summary
- As of February 7, 2025, FATE annual operating income is -$190.51 million, with the most recent change of +$117.88 million (+38.22%) on December 31, 2023.
- During the last 3 years, FATE annual operating profit has fallen by -$62.43 million (-48.74%).
- FATE annual operating profit is now -1333.17% below its all-time high of -$13.29 million, reached on December 31, 2011.
Performance
FATE Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$52.38 M
-$7.29 M-16.18%
September 30, 2024
Summary
- As of February 7, 2025, FATE quarterly operating income is -$52.38 million, with the most recent change of -$7.29 million (-16.18%) on September 30, 2024.
- Over the past year, FATE quarterly operating profit has dropped by -$1.10 million (-2.14%).
- FATE quarterly operating profit is now -1460.70% below its all-time high of -$3.36 million, reached on March 31, 2013.
Performance
FATE Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$196.60 M
-$1.10 M-0.56%
September 30, 2024
Summary
- As of February 7, 2025, FATE TTM operating income is -$196.60 million, with the most recent change of -$1.10 million (-0.56%) on September 30, 2024.
- Over the past year, FATE TTM operating profit has increased by +$10.25 million (+4.96%).
- FATE TTM operating profit is now -5286.38% below its all-time high of -$3.65 million, reached on September 30, 2012.
Performance
FATE TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
FATE Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.2% | -2.1% | +5.0% |
| 3 y3 years | -48.7% | -83.2% | +25.1% |
| 5 y5 years | -183.9% | -51.9% | -71.3% |
FATE Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.2% | -83.2% | +39.4% | -3.2% | +37.3% |
| 5 y | 5-year | -89.1% | +38.2% | -83.2% | +39.4% | -95.2% | +37.3% |
| alltime | all time | -1333.2% | +38.2% | -1460.7% | +39.4% | -5286.4% | +37.3% |
Fate Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$52.38 M(+16.2%) | -$196.60 M(+0.6%) |
| Jun 2024 | - | -$45.08 M(-11.7%) | -$195.50 M(-8.2%) |
| Mar 2024 | - | -$51.07 M(+6.2%) | -$212.99 M(+11.8%) |
| Dec 2023 | -$190.51 M(-38.2%) | -$48.08 M(-6.2%) | -$190.51 M(-7.9%) |
| Sep 2023 | - | -$51.28 M(-18.0%) | -$206.85 M(-14.5%) |
| Jun 2023 | - | -$62.56 M(+118.8%) | -$241.97 M(-7.8%) |
| Mar 2023 | - | -$28.59 M(-55.6%) | -$262.51 M(-14.9%) |
| Dec 2022 | -$308.39 M(+42.1%) | -$64.42 M(-25.4%) | -$308.39 M(-1.6%) |
| Sep 2022 | - | -$86.39 M(+3.9%) | -$313.35 M(+11.3%) |
| Jun 2022 | - | -$83.11 M(+11.6%) | -$281.58 M(+14.8%) |
| Mar 2022 | - | -$74.47 M(+7.3%) | -$245.25 M(+13.0%) |
| Dec 2021 | -$216.99 M(+69.4%) | -$69.38 M(+27.0%) | -$216.99 M(+19.9%) |
| Sep 2021 | - | -$54.62 M(+16.8%) | -$181.01 M(+14.7%) |
| Jun 2021 | - | -$46.78 M(+1.2%) | -$157.88 M(+12.9%) |
| Mar 2021 | - | -$46.21 M(+38.4%) | -$139.80 M(+9.1%) |
| Dec 2020 | -$128.09 M(+27.2%) | -$33.40 M(+6.1%) | -$128.09 M(+3.5%) |
| Sep 2020 | - | -$31.49 M(+9.7%) | -$123.76 M(+3.7%) |
| Jun 2020 | - | -$28.71 M(-16.8%) | -$119.40 M(+4.0%) |
| Mar 2020 | - | -$34.49 M(+18.6%) | -$114.77 M(+13.9%) |
| Dec 2019 | -$100.73 M(+50.1%) | -$29.08 M(+7.2%) | -$100.73 M(+14.0%) |
| Sep 2019 | - | -$27.12 M(+12.6%) | -$88.39 M(+13.4%) |
| Jun 2019 | - | -$24.08 M(+17.8%) | -$77.96 M(+6.1%) |
| Mar 2019 | - | -$20.45 M(+22.1%) | -$73.48 M(+9.5%) |
| Dec 2018 | -$67.09 M | -$16.74 M(+0.3%) | -$67.09 M(+7.2%) |
| Sep 2018 | - | -$16.69 M(-14.9%) | -$62.59 M(+11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$19.61 M(+39.5%) | -$56.24 M(+21.7%) |
| Mar 2018 | - | -$14.05 M(+14.8%) | -$46.21 M(+9.7%) |
| Dec 2017 | -$42.13 M(+31.8%) | -$12.24 M(+18.4%) | -$42.13 M(+12.2%) |
| Sep 2017 | - | -$10.34 M(+8.0%) | -$37.53 M(+5.5%) |
| Jun 2017 | - | -$9.57 M(-4.0%) | -$35.58 M(+4.6%) |
| Mar 2017 | - | -$9.97 M(+30.3%) | -$34.02 M(+6.4%) |
| Dec 2016 | -$31.96 M(+15.0%) | -$7.65 M(-8.8%) | -$31.96 M(+2.4%) |
| Sep 2016 | - | -$8.39 M(+4.8%) | -$31.22 M(+7.1%) |
| Jun 2016 | - | -$8.00 M(+1.1%) | -$29.16 M(+2.8%) |
| Mar 2016 | - | -$7.92 M(+14.5%) | -$28.37 M(+2.1%) |
| Dec 2015 | -$27.78 M(+11.6%) | -$6.91 M(+9.2%) | -$27.78 M(+3.6%) |
| Sep 2015 | - | -$6.33 M(-12.3%) | -$26.81 M(+1.3%) |
| Jun 2015 | - | -$7.22 M(-1.4%) | -$26.47 M(+4.7%) |
| Mar 2015 | - | -$7.32 M(+23.2%) | -$25.29 M(+1.6%) |
| Dec 2014 | -$24.90 M(+40.9%) | -$5.94 M(-0.7%) | -$24.90 M(+4.4%) |
| Sep 2014 | - | -$5.98 M(-0.9%) | -$23.86 M(+3.6%) |
| Jun 2014 | - | -$6.04 M(-12.9%) | -$23.03 M(+8.3%) |
| Mar 2014 | - | -$6.94 M(+41.5%) | -$21.26 M(+20.3%) |
| Dec 2013 | -$17.68 M(+30.4%) | -$4.90 M(-4.8%) | -$17.68 M(+5.1%) |
| Sep 2013 | - | -$5.15 M(+20.6%) | -$16.82 M(+9.8%) |
| Jun 2013 | - | -$4.27 M(+27.2%) | -$15.32 M(+38.6%) |
| Mar 2013 | - | -$3.36 M(-17.0%) | -$11.05 M(+43.6%) |
| Dec 2012 | -$13.56 M(+2.0%) | -$4.04 M(+10.8%) | -$7.69 M(+110.8%) |
| Sep 2012 | - | -$3.65 M | -$3.65 M |
| Dec 2011 | -$13.29 M | - | - |
FAQ
- What is Fate Therapeutics annual operating income?
- What is the all time high annual operating profit for Fate Therapeutics?
- What is Fate Therapeutics annual operating profit year-on-year change?
- What is Fate Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Fate Therapeutics?
- What is Fate Therapeutics quarterly operating profit year-on-year change?
- What is Fate Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Fate Therapeutics?
- What is Fate Therapeutics TTM operating profit year-on-year change?
What is Fate Therapeutics annual operating income?
The current annual operating profit of FATE is -$190.51 M
What is the all time high annual operating profit for Fate Therapeutics?
Fate Therapeutics all-time high annual operating income is -$13.29 M
What is Fate Therapeutics annual operating profit year-on-year change?
Over the past year, FATE annual operating income has changed by +$117.88 M (+38.22%)
What is Fate Therapeutics quarterly operating income?
The current quarterly operating profit of FATE is -$52.38 M
What is the all time high quarterly operating profit for Fate Therapeutics?
Fate Therapeutics all-time high quarterly operating income is -$3.36 M
What is Fate Therapeutics quarterly operating profit year-on-year change?
Over the past year, FATE quarterly operating income has changed by -$1.10 M (-2.14%)
What is Fate Therapeutics TTM operating income?
The current TTM operating profit of FATE is -$196.60 M
What is the all time high TTM operating profit for Fate Therapeutics?
Fate Therapeutics all-time high TTM operating income is -$3.65 M
What is Fate Therapeutics TTM operating profit year-on-year change?
Over the past year, FATE TTM operating income has changed by +$10.25 M (+4.96%)